News

FDA’s Patient Network supports people who are looking for reliable information about medical products and their approvals, clinical trials, and other treatment options.

FDA’s Patient Network supports people who are looking for reliable information about medical products and their approvals, clinical trials, and other treatment options.

It is estimated that 5-15% of glaucoma patients, reportedly spending billions of dollars annually, take some form of alternative medication based only on their impression that it will help treat their glaucoma.

It is estimated that 5-15% of glaucoma patients, reportedly spending billions of dollars annually, take some form of alternative medication based only on their impression that it will help treat their glaucoma.

Glaucoma develops in some patients with a condition called exfoliation syndrome. Also known as pseudoexfoliation, it is caused by the abnormal accumulation of protein in the drainage system and other structures of the eye.

Glaucoma develops in some patients with a condition called exfoliation syndrome. Also known as pseudoexfoliation, it is caused by the abnormal accumulation of protein in the drainage system and other structures of the eye.

Glaucoma is a very misunderstood disease. Often, people don't realize the severity or who is affected.

Glaucoma is a very misunderstood disease. Often, people don't realize the severity or who is affected.

How can we better diagnose or track the progression of glaucoma? The discovery of improved biomarkers for early detection or disease progression has the potential to radically change treatment of glaucoma.

How can we better diagnose or track the progression of glaucoma? The discovery of improved biomarkers for early detection or disease progression has the potential to radically change treatment of glaucoma.

Physicians at the Virginia Commonwealth University Medical Center have become the first in Virginia to successfully implant a telescope in a patient's eye to treat macular degeneration. The telescope implant is designed to correct end-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans...

The ongoing dance between a virus and its host distinctly shapes how the virus evolves. While human adenoviruses typically cause mild infections, recent reports have described newly characterized adenoviruses that can cause severe, sometime fatal, human infections...

Proliferative vitreoretinopathy (PVR), or the formation of scar tissue in the eye, is a serious, sight-threatening complication in people recovering from surgical repair of retinal detachment. PVR is difficult to predict, lacks effective treatment options, and substantially reduces an individual's quality of life. Each year 55,000 people are at risk for developing PVR in the United States alone...

Researchers have discovered that using two kinds of therapy in tandem may be a knockout combo against inherited disorders that cause blindness. While their study focused on man's best friend, the treatment could help restore vision in people, too...

But there's still inexplicable fivefold difference in rates across England, similar to wide discrepancies in tonsil removal Rates of surgery to correct childhood squint in England have tumbled over the past 50 years, finds research published online in the British Journal of Ophthalmology...

Researchers at Nottingham Trent University have created an artificial eye with a cosmetic pupil that can dilate and contract in response to light. Using smart materials, the prototype aims to solve the longstanding problem of eye loss victims having two different sized pupils at night or in bright sunshine...

The retina is a highly vascularized tissue, but too much or too little vascularization can lead to visual impairment and diseases such as familial exudative vitreoretinopathy or macular degeneration...

Brain researchers at Barrow Neurological Institute have discovered that we explore the world with our eyes in a different way than previously thought. Their results advance our understanding of how healthy observers and neurological patients interact and glean critical information from the world around them. The research team was led by Dr...

Launched in 2002, the original team of four Catalyst for a Cure investigators has made a significant impact on the field of glaucoma research, helping to redefine our understanding of how glaucoma steals sight

Launched in 2002, the original team of four Catalyst for a Cure investigators has made a significant impact on the field of glaucoma research, helping to redefine our understanding of how glaucoma steals sight